Down syndrome: Advances in molecular biology and the neurosciences

被引:71
|
作者
Capone, GT
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[2] Kennedy Krieger Inst, Down Syndrome Clin, Div Neurol & Dev Med, Baltimore, MD 21205 USA
来源
关键词
Down syndrome; chromosome; 21; gene expression; brain development; neurobiology; cognitive impairment; Alzheimer's disease;
D O I
10.1097/00004703-200102000-00007
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The entire DNA sequence for human chromosome 21 is now complete. and it is predicted to contain only about 225 genes, which is approximately three-fold fewer than the number initially predicted just 10 years ago. Despite this remarkable achievement, very little is known about the mechanism(s) whereby increased gene copy number (gene dosage) results in the characteristic phenotype of Down syndrome. Although many of the phenotypic twits show targe individual variation. neuromotor dysfunction and cognitive and language impairment are observed in virtually all individuals. Currently. there are no efficacious biomedical treatments for these central nervous system-associated impairments. To develop novel therapeutic strategies, the effects of gene dosage imbalance need to be understood within the framework of those critical biological events that regulate brain organization and function.
引用
收藏
页码:40 / 59
页数:20
相关论文
共 50 条
  • [1] MOLECULAR BIOLOGY AMONG NEUROSCIENCES
    SCHMITT, FO
    [J]. ARCHIVES OF NEUROLOGY, 1967, 17 (06) : 561 - &
  • [2] The molecular biology of Down Syndrome - Preface
    Lubec, G
    [J]. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (57): : V - V
  • [3] Diagnosis of Down syndrome by molecular biology tools
    Bouizegarene, P.
    Ameziane, N.
    Bogard, M.
    Deybach, J. -C.
    Lamoril, J.
    [J]. IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2008, 23 (01): : 1 - 10
  • [4] Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
    Faundez, Victor
    De Toma, Ilario
    Bardoni, Barbara
    Bartesaghi, Renata
    Nizetic, Dean
    de la Torre, Rafael
    Kadosh, Roi Cohen
    Herault, Yann
    Dierssen, Mara
    Potier, Marie-Claude
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (06) : 675 - 690
  • [5] Translating molecular advances in Down syndrome and fragile X syndrome into therapy
    Dierssen, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S565 - S565
  • [6] THE BIOLOGY OF DOWN SYNDROME
    SMITH, GF
    WARREN, ST
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 450 (JUN) : 1 - 9
  • [7] The biology of Down syndrome
    Epstein, CJ
    [J]. CYTOGENETICS AND CELL GENETICS, 1997, 77 : 1 - 1
  • [8] Advances in molecular characterization of myeloid proliferations associated with Down syndrome
    Li, Jixia
    Kalev-Zylinska, Maggie L.
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [9] Editorial: Advances in biology and treatment of malignant brain gliomas stem cells and neurosciences
    Maira, Giulio
    Fernandez, Eduardo
    [J]. NEUROLOGICAL RESEARCH, 2006, 28 (05) : 471 - 473
  • [10] Neurological advances in Down syndrome
    Lott, IT
    [J]. CYTOGENETICS AND CELL GENETICS, 1997, 77 : 18 - 18